SOPHARMA (SPH): Sales revenues for the first two months of 2018 - raport 12
Raport ESPI
UNI - EN REPORT No12/2018
Sofia, Bulgaria, March 6, 2018 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for February 2018 the Company recorded an increase of sales revenues of 2% compared to the same month of 2017, including 8% increase of domestic sales and same level of export sales.
For the first two months of this year, revenues from sales increased by 1% compared to the same period of 2017, including 2% increase of export sales and same level of domestic sales.
